IRIS
LAVOLPE, Vito Grazio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 903
EU - Europa 266
AS - Asia 131
OC - Oceania 1
Totale 1.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 901
SE - Svezia 94
CN - Cina 91
DE - Germania 38
UA - Ucraina 33
VN - Vietnam 30
GB - Regno Unito 29
IT - Italia 26
FI - Finlandia 19
BE - Belgio 13
FR - Francia 6
HK - Hong Kong 5
IN - India 4
CA - Canada 2
CH - Svizzera 2
IE - Irlanda 2
RU - Federazione Russa 2
AU - Australia 1
CZ - Repubblica Ceca 1
IR - Iran 1
NL - Olanda 1
Totale 1.301
Salva come PNG Salva come JPEG
Città #
Chandler 117
Fairfield 106
Woodbridge 85
Jacksonville 77
Nyköping 67
Houston 57
Ann Arbor 55
Ashburn 48
Seattle 39
Wilmington 36
Beijing 31
Cambridge 31
Dong Ket 28
Bari 20
Kansas City 19
Brooklyn 17
Lawrence 16
Nanjing 16
Roxbury 16
New York 15
Brussels 13
Des Moines 13
Hebei 10
Jiaxing 9
Princeton 9
Boardman 8
San Diego 7
Munich 4
Ningbo 4
Pune 4
Shenyang 4
West Jordan 4
Grafing 3
Los Angeles 3
Paris 3
Tianjin 3
Zhengzhou 3
Changsha 2
Dearborn 2
Dublin 2
Hanoi 2
Hong Kong 2
London 2
Nanchang 2
Redwood City 2
St Albans 2
Taizhou 2
Toronto 2
Boydton 1
Brno 1
Chiswick 1
Chongqing 1
Düsseldorf 1
Elk Grove Village 1
Fuzhou 1
Gloucester 1
Inglewood 1
Jinan 1
Kilburn 1
Manchester 1
Marseille 1
Milan 1
New Bedfont 1
Ostuni 1
Redmond 1
Sabz 1
Saint Petersburg 1
Santa Marinella 1
Segrate 1
St Petersburg 1
Strasbourg 1
Sydney 1
Tappahannock 1
Trani 1
Utrecht 1
Uxbridge 1
Washington 1
Totale 1.051
Salva come PNG Salva come JPEG
Nome #
1 - 10 of 10 One page. 1: Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia 155
null 109
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 102
A case of unilateral burning mouth syndrome of neuropathic origin 99
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 94
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies 94
A Case of Unilateral Burning Mouth Syndrome of Neuropathic Origin 89
Effects of preservation solutions on blood 84
Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres 76
C'era una volta la Didattica...e adesso? 70
A case of vacuolar myopathy during the course of chronic hepatitis C 64
CORRELATIONS BETWEEN NEUTRALIZING ANTIBODIES PRODUCTION AND CLINICAL OUTCOMES: ANALYSIS IN A POPULATION- BASED SURVEILLANCE ITALIAN STUDY OF INTERFERON BETA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS 57
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 45
L'open access e l'Università. Il modello proposto dalla Facoltà di Medicina e Chirurgia di Bari 44
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients 33
Università e modelli di web-leasrning 31
Pulmonary arterial hypertension and hiv infection 22
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study. 19
Left ventricular dysfunction in cardiac metastatic melanoma: nivolumab induced immunotoxicity or direct myocardial damage? 19
Wath's behind pericardial effusion? A difficult differential diagnosis 12
Totale 1.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201991 0 0 0 0 0 0 0 0 0 0 38 53
2019/2020295 52 20 10 19 27 19 31 21 32 17 43 4
2020/2021214 20 7 33 10 17 4 17 9 22 26 9 40
2021/2022148 9 12 0 8 5 10 6 7 6 23 28 34
2022/2023321 46 57 18 25 47 32 3 34 51 3 3 2
2023/202493 8 21 5 14 7 23 5 3 2 5 0 0
Totale 1.318